U-Blot® Research Grade AnzurstobartCat. No. WA2428$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade AnzurstobartCat. No. WA2428
U-Blot® Research Grade AnvatabartCat. No. WA2427
U-Blot® Research Grade AnumigilimabCat. No. WA2426
U-Blot® Research Grade Anti-ZEBOV GP/Glycoprotein (Zmapp)Cat. No. WA2425
U-Blot® Research Grade Anti-ZEBOV GP/Glycoprotein (ANP-015)Cat. No. WA2424
U-Blot® Research Grade Anti-VSIG4/CRIg Antibody (VTX-1218)Cat. No. WA2423
U-Blot® Research Grade Anti-VSIG4/CRIg Antibody (EU103)Cat. No. WA2422
U-Blot® Research Grade Anti-Urushiol (ALG-991)Cat. No. WA2421
U-Blot® Research Grade Anti-TROP2 & Anti-HSG Bispecific Antibody (TF12)Cat. No. WA2420
U-Blot® Research Grade Anti-TNFa/TNF-alpha (CDP571)Cat. No. WA2419
U-Blot® Research Grade Anti-TCR αβ/alpha-beta TCRCat. No. WA2418
U-Blot® Research Grade Anti-SARS-CoV-2 Spikeprotein (RBD) Antibody (BA7535)Cat. No. WA2417